In addition, treatment of vhl−/− zebrafish embryos with the specific HIF2a inhibitor Compound 76 significantly attenuated the pronephric phenotype, demonstrating that the phenotype is HIF2a driven and highlighting the value of zebrafish models for the discovery of novel drugs targeting VHL disease and ccRCC. Here, EPAS1 is linked to nonpapillary renal cell carcinoma.